Minimizing Leukemia Relapse: A Phase I, Dose Escalation Study of Decitabine in High Risk Pediatric Leukemia Post Allogeneic Transplant
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 05 Oct 2017
At a glance
- Drugs Decitabine (Primary)
- Indications Acute lymphoblastic leukaemia; Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Adverse reactions
- 29 Nov 2016 Status changed from recruiting to active, no longer recruiting.
- 02 Nov 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 27 Oct 2014 New trial record